T-EVEN LABS

We are building a therapeutics company for the post-antibiotic age, and are looking for investors who want to make a fundamental difference in the medical, biotechnology, and agriculture spaces. Antibiotics have driven an evolutionary revolution in bacteria, leading to the spread of resistance genes throughout populations of pathogenic bacteria, and leading to increases in deaths due to previously curable diseases. At T-Even, we are developing new therapeutic cocktails for use in the first-aid, emergency medicine and agricultural sectors. These cocktails will be formulated using natural and engineered bacterial viruses to prevent, control, and resolve infections with common bacterial pathogens.